JP2022523710A5 - - Google Patents
Info
- Publication number
- JP2022523710A5 JP2022523710A5 JP2021544141A JP2021544141A JP2022523710A5 JP 2022523710 A5 JP2022523710 A5 JP 2022523710A5 JP 2021544141 A JP2021544141 A JP 2021544141A JP 2021544141 A JP2021544141 A JP 2021544141A JP 2022523710 A5 JP2022523710 A5 JP 2022523710A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019073402 | 2019-01-28 | ||
| CNPCT/CN2019/073402 | 2019-01-28 | ||
| PCT/US2020/014425 WO2020159754A2 (en) | 2019-01-28 | 2020-01-21 | Antibodies specific to cd44 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022523710A JP2022523710A (ja) | 2022-04-26 |
| JP2022523710A5 true JP2022523710A5 (https=) | 2023-02-01 |
| JPWO2020159754A5 JPWO2020159754A5 (https=) | 2023-02-01 |
| JP7656330B2 JP7656330B2 (ja) | 2025-04-03 |
Family
ID=71840370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544141A Active JP7656330B2 (ja) | 2019-01-28 | 2020-01-21 | Ｃｄ４４に特異的な抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12311031B2 (https=) |
| EP (1) | EP3917952A4 (https=) |
| JP (1) | JP7656330B2 (https=) |
| CN (1) | CN113474362B (https=) |
| AU (1) | AU2020216780B2 (https=) |
| TW (1) | TWI870378B (https=) |
| WO (1) | WO2020159754A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4350317A4 (en) * | 2021-05-28 | 2024-10-02 | NSK Ltd. | ROLLING DEVICE STATE DETECTION METHOD, DETECTION DEVICE, AND PROGRAM |
| CN114213538B (zh) * | 2021-12-24 | 2022-07-08 | 北京市神经外科研究所 | Cd44抗体、嵌合抗原受体及其应用 |
| CN114316049B (zh) * | 2021-12-24 | 2022-08-09 | 北京市神经外科研究所 | Cd44抗体、嵌合抗原受体及其应用 |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| JP2025535447A (ja) * | 2022-10-19 | 2025-10-24 | マルチチュード・セラピューティックス・インコーポレーテッド | 抗体－薬物コンジュゲート、その調製方法および使用 |
| US12311033B2 (en) | 2023-05-31 | 2025-05-27 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025076127A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025179294A2 (en) | 2024-02-22 | 2025-08-28 | Capstan Therapeutics, Inc. | Immune engineering amplification |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0767378A1 (de) * | 1993-06-22 | 1997-04-09 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Diagnose und Analyse von Magenkarzinomen |
| WO2005046597A2 (en) * | 2003-11-07 | 2005-05-26 | Brigham And Womens's Hospital, Inc. | Antibodies to cd44 glycoforms and uses thereof |
| US20080171042A1 (en) * | 2004-05-07 | 2008-07-17 | University Of Florida Research Foundation, Inc. | Cd44 Variants As Therapeutic Targets |
| EP1914242A1 (en) * | 2006-10-19 | 2008-04-23 | Sanofi-Aventis | Novel anti-CD38 antibodies for the treatment of cancer |
| US20080199426A1 (en) * | 2007-01-11 | 2008-08-21 | Sukhatme Vikas P | Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders |
| EP2467491A4 (en) * | 2009-08-21 | 2014-04-02 | Sinai School Medicine | METHOD OF USE OF CD44 FUSION PROTEINS FOR CANCER TREATMENT |
| SI3194434T1 (sl) * | 2014-09-15 | 2019-11-29 | Molmed Spa | Himerni antigenski receptorji |
| US20170014524A1 (en) * | 2015-07-15 | 2017-01-19 | The California Institute For Biomedical Research | Auristatin-antibody conjugates and uses thereof |
| CN108290939B (zh) * | 2015-10-16 | 2023-01-13 | 纽约市哥伦比亚大学理事会 | 用于抑制谱系特异性抗原的组合物和方法 |
| AU2017239637A1 (en) * | 2016-03-29 | 2018-11-15 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| CN113896793B (zh) * | 2021-09-30 | 2023-05-26 | 港科鹏禾生物(苏州)有限公司 | 一种抗人il-17rc的单克隆抗体及其应用 |
-
2020
- 2020-01-21 EP EP20747727.4A patent/EP3917952A4/en active Pending
- 2020-01-21 CN CN202080011128.1A patent/CN113474362B/zh active Active
- 2020-01-21 AU AU2020216780A patent/AU2020216780B2/en active Active
- 2020-01-21 WO PCT/US2020/014425 patent/WO2020159754A2/en not_active Ceased
- 2020-01-21 JP JP2021544141A patent/JP7656330B2/ja active Active
- 2020-01-21 TW TW109102201A patent/TWI870378B/zh active
-
2021
- 2021-07-27 US US17/386,197 patent/US12311031B2/en active Active